Organic compounds -- part of the class 532-570 series inventions 10/08

20080262231 - Processes for preparing morphinans and intermediates thereof: The present invention is directed to processes for the synthesis of morphinans. In particular, a process for cyclizing a β,γ-bicyclic ketone compound to form a nordihydrothebainone product using the Grewe cyclization reaction is improved by forming a reaction mixture comprising a β,γ-bicyclic ketone compound, a cyclizing acid and a water... Agent: Mallinckrodt Inc.

20080262232 - Processes for the production of polymorphic forms of rifaximin: Crystalline polymorphous forms of rifaximin (INN) antibiotic named rifaximin α and rifaximin β, and a poorly crystalline form named rifaximin γ, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in... Agent: Biotechnology Law Group C/o Portfolioip

20080262233 - Synthesis of preffered isomer fractions of n, n-diethyldecahydroquinolinium cation: The present invention relates to a process for synthesizing trans-N,N-diethyldecahydroquinolinium cation or a mixture of a cis-N,N-diethyldecahydroquinolinium cation and a trans-N,N-diethyldecahydroquinolinium cation.... Agent: Chevron Corporation

20080262234 - Process for preparing n, n-substituted carbamoyl halides: The present invention relates to a new and useful process for preparing N,N-substituted carbamoyl halides from secondary amines, carbon dioxide, trialkylsilyl chloride and a halogenating agent.... Agent: Glaxosmithkline Corporate Intellectual Property, Mai B482

20080262235 - Method and apparatus for producing oxidized compound: There is provided a method and an apparatus for producing an oxidized compound, which includes measuring an electric potential of an oxidation reaction solution for producing an oxidized compound by an oxidation reaction, and determining an end point of the oxidation reaction on the basis of a predefined decrease of... Agent: Edwards Angell Palmer & Dodge LLP

20080262237 - Black pigment, black pigment dispersion and black resin composition comprising the same: The present invention provides a black pigment consisting of an oxonol compound having a mean particle diameter ranging from 0.01 to 10.0 micrometers, and a black pigment dispersion and a black resin composition comprising the black pigment.... Agent: Sughrue Mion, PLLC

20080262236 - Process for the preparation of 4-carbonyl)amino]phenoxy}-n-methylpyridine-2-carboxamide: The present invention relates to a process for preparing 4-{4-[({[4-chloro-3-(trifluoro-methyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide and its tosylate salt.... Agent: Barbara A. Shimei Director, Patents & Licensing

20080262238 - Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound: wherein TC designates a linkage to a former generation in the direction to a focal point of the dendron or a core of the dendrimer; TT designates a linkage to a next generation in the direction to a terminal; X is a divalent group comprised of at least one heteroatom;... Agent: Buchanan, Ingersoll & Rooney PC

20080262239 - Process for producing enantiomer of amlodipine in high optical purity: The present invention relates to a process for preparation of optically pure (S)-amlodipine-L-hemitartrate DMF solvate comprising the steps of treating (R,S) amlodipine base with L-tartaric acid in the presence of dimethyl formamide and a co-solvent. The invention also relates to a process for converting (R) or (S)-amlopidine-L-hemitartrate DMF solvate into... Agent: Foley And Lardner LLP Suite 500

20080262231 - Processes for preparing morphinans and intermediates thereof: The present invention is directed to processes for the synthesis of morphinans. In particular, a process for cyclizing a β,γ-bicyclic ketone compound to form a nordihydrothebainone product using the Grewe cyclization reaction is improved by forming a reaction mixture comprising a β,γ-bicyclic ketone compound, a cyclizing acid and a water... Agent: Mallinckrodt Inc.

20080262232 - Processes for the production of polymorphic forms of rifaximin: Crystalline polymorphous forms of rifaximin (INN) antibiotic named rifaximin α and rifaximin β, and a poorly crystalline form named rifaximin γ, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in... Agent: Biotechnology Law Group C/o Portfolioip

20080262233 - Synthesis of preffered isomer fractions of n, n-diethyldecahydroquinolinium cation: The present invention relates to a process for synthesizing trans-N,N-diethyldecahydroquinolinium cation or a mixture of a cis-N,N-diethyldecahydroquinolinium cation and a trans-N,N-diethyldecahydroquinolinium cation.... Agent: Chevron Corporation

20080262234 - Process for preparing n, n-substituted carbamoyl halides: The present invention relates to a new and useful process for preparing N,N-substituted carbamoyl halides from secondary amines, carbon dioxide, trialkylsilyl chloride and a halogenating agent.... Agent: Glaxosmithkline Corporate Intellectual Property, Mai B482

20080262235 - Method and apparatus for producing oxidized compound: There is provided a method and an apparatus for producing an oxidized compound, which includes measuring an electric potential of an oxidation reaction solution for producing an oxidized compound by an oxidation reaction, and determining an end point of the oxidation reaction on the basis of a predefined decrease of... Agent: Edwards Angell Palmer & Dodge LLP

20080262237 - Black pigment, black pigment dispersion and black resin composition comprising the same: The present invention provides a black pigment consisting of an oxonol compound having a mean particle diameter ranging from 0.01 to 10.0 micrometers, and a black pigment dispersion and a black resin composition comprising the black pigment.... Agent: Sughrue Mion, PLLC

20080262236 - Process for the preparation of 4-carbonyl)amino]phenoxy}-n-methylpyridine-2-carboxamide: The present invention relates to a process for preparing 4-{4-[({[4-chloro-3-(trifluoro-methyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide and its tosylate salt.... Agent: Barbara A. Shimei Director, Patents & Licensing

20080262238 - Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound: wherein TC designates a linkage to a former generation in the direction to a focal point of the dendron or a core of the dendrimer; TT designates a linkage to a next generation in the direction to a terminal; X is a divalent group comprised of at least one heteroatom;... Agent: Buchanan, Ingersoll & Rooney PC

20080262239 - Process for producing enantiomer of amlodipine in high optical purity: The present invention relates to a process for preparation of optically pure (S)-amlodipine-L-hemitartrate DMF solvate comprising the steps of treating (R,S) amlodipine base with L-tartaric acid in the presence of dimethyl formamide and a co-solvent. The invention also relates to a process for converting (R) or (S)-amlopidine-L-hemitartrate DMF solvate into... Agent: Foley And Lardner LLP Suite 500

20080255361 - Process for producing ortho-metalated complex of iridium with homoligand: Disclosed is a process for producing an ortho-metalated 1:3 complex of iridium with homoligands which is useful as a luminous material for an organic EL device in high yield at high purity in a short time by a simple procedure. An example of the complex is tris(2-phenylpyridine)iridium(III) and this complex... Agent: Birch Stewart Kolasch & Birch

20080255362 - Cyclic amide derivative, and its production and use: wherein R1 represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent chain hydrocarbon group, a represents 0, 1, or 2, X1 represents an optionally substituted lower alkylene or an optionally substituted lower alkenylene, Y1 represents —C(O)—, —S(O)—... Agent: Hamre, Schumann, Mueller & Larson, P.C.

20080255363 - Novel form of s-omeprazole: The present invention relates to a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of... Agent: White & Case LLP Patent Department

20080255364 - Method for the production a-chloroalkylpyridyl ketones and/or the hydrochlorides thereof: Process for preparing unsubstituted or nuclear-substituted α-chloroalkyl pyridyl ketones and/or their hydrochlorides by reacting the corresponding unsubstituted or nuclear-substituted alkyl pyridyl ketone hydrochlorides with sulfuryl chloride at a reaction temperature of from −25 to 70° C. (248 to 343 K) and a pressure of 0.05 to 0.2 MPa abs, in... Agent: Connolly Bove Lodge & Hutz LLP

20080255365 - Microparticulate form of a tetrahydropyridine derivative: The invention relates to a microparticulate form of 1-[2-(2-naphthyl)-ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine hydrochloride consisting of particles for which at least 55% of the population have a diameter below 50 micrometers, and to pharmaceutical compositions in which it is present.... Agent: Andrea Q. Ryan Sanofi-aventis U.s. LLC

20080249308 - Complexes of ruthenium with 2-(aminomethyl)pyridines and phosphines, their preparation and use as catalysts: The invention relates to a new class of ruthenium (II) complexes containing as ligands 2-(aminomethyl)pyridines and phosphines, proven to be extremely active catalysts in the reduction of ketones to alcohols via hydrogen transfer. By using 2-propanol as the hydrogen source with the ruthenium complexes, high yields of the corresponding alcohol... Agent: Collard & Roe, P.C.

20080249309 - Organic semiconductor materials and precursors thereof: The present teachings provide novel organic semiconductor compounds and their soluble precursors, methods for preparing these compounds and precursors, as well as compositions, materials, articles, structures, and devices that incorporate such compounds.... Agent: Kirkpatrick & Lockhart Preston Gates Ellis LLP (formerly Kirkpatrick & Lockhart Nicholson Graham)

20080249310 - Process for the preparation of (2r,3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r,3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester: and to a process for the preparation of said compound of formula (1), wherein a reaction mixture comprising the two enantiomers (2R,3S) and (2S,3R) of trans-3-aryl glycidic acid alkyl ester and the two enantiomers (2R,3R) and (2S,3S) of cis-3-aryl glycidic acid alkyl ester, said mixture being enantiomerically and diastereomerically enriched... Agent: Nixon & Vanderhye, PC

20080249311 - Preparation of clopidogrel and its analogues methyl tetrahydrothienopyridine acetate compuunds: d

20080249312 - Process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3')quiniclidine: An industrially acceptable process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine. The cis-isomer of 2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine is known generally as Cevimeline.... Agent: Ivor M. Hughes, Barrister & Solicitor, Patent & Trademark Agents

20080249313 - Process for the preparation of pyridylcarboxylic amides and esters: The invention relates to a process for the preparation of pyridylcarboxylic amides and esters I, Formula (I) wherein Hal, X and R1 have the meanings given in claim 1, which comprises the following steps: (a) heating a mixture consisting essentially of trichloromethylpyridine II, Formula (II), wherein Hal has the meaning... Agent: Brinks, Hofer, Gilson & Lione

20080249314 - Optical resolution method of amlodipine: The present invention relates to a method for optical resolution of amlodipines by using isopropanol solvent and optically active O,O′-dibenzoyl tartaric acid as chiral reagent. More particularly, the present invention relates to a method comprising (a) obtaining (R)— or (S)-amlodipine dibenzoyl tartrate salt or solvate thereof by reacting (R,S)-amlodipines with... Agent: Osha Liang L.L.P.

20080242864 - Process for the semisynthesis of deserpidine: The present invention relates to an efficient procedure for the synthesis of deserpidine (Ia), starting from reserpic acid lactone (II) via the intermediate 11-O-demethyl reserpic acid lactone (III).... Agent: Mathews, Shepherd, Mckay, & Bruneau, P.A.

20080242865 - Processes for the preparation of hydroxylamines: The present invention relates generally to novel methods for the synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates... Agent: Elmore Patent Law Group, PC

20080242866 - Synthesis of anthranilamides: e

20080242867 - Acetone solvate of phthaloyl amlodipine: An acetone solvate of phthaloyl amlodipine, as well as a process for its preparation including dissolving phthaloyl amlodipine in acetone and cooling the mixture. The present invention also comprises a method for the synthesis of amlodipine, its salts or solvates, which comprises the use of an acetone solvate of phthaloyl... Agent: Intellectual Property / Technology Law